Foley Partner Patrick Daugherty was quoted in an article that appeared on Securities Law360 on October 13, 2009 titled “Stoneridge Bill Sparks Enforcement Debate.” Daugherty discusses pending legislation proposing to reverse the U.S. Supreme Court’s ruling in Stoneridge Investment Partners LLC v. Scientific-Atlanta Inc., noting that overturning the decision could have an impact on business transactions by potentially exposing a wide variety of players to aiding and abetting lawsuits. He adds that the pressure on plaintiffs to settle in the face of frivolous securities lawsuits can be extreme, particularly when plaintiffs are facing billion-dollar claims.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”